Gujarat Kidney Super Speciality Ltd vs Kovai Medical Center Hospital Ltd Stock Comparison
Gujarat Kidney Super Speciality Ltd vs Kovai Medical Center Hospital Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Gujarat Kidney & Super Speciality Ltd is ₹ 176.95 as of 23 Oct 15:30
. The P/E Ratio of Gujarat Kidney & Super Speciality Ltd changed from 51.4 on March 2026 to 51.4 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Kovai Medical Center & Hospital Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Gujarat Kidney & Super Speciality Ltd changed from ₹ 798.29 crore on March 2026 to ₹ 798.29 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Kovai Medical Center & Hospital Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The revenue of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 34.98 crore as compare to the Mar '26 revenue of ₹ 31.29 crore. This represent the growth of 11.79% The revenue of Kovai Medical Center & Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 9.07 crore as compare to the Mar '26 ebitda of ₹ 7.01 crore. This represent the growth of 29.39% The ebitda of Kovai Medical Center & Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gujarat Kidney & Super Speciality Ltd changed from ₹ 2.96 crore to ₹ 5.32 crore over 8 quarters. This represents a CAGR of 34.06%
The net profit of Kovai Medical Center & Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0%
The Dividend Payout of Gujarat Kidney & Super Speciality Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Kovai Medical Center & Hospital Ltd changed from 4.22 % on March 2021 to 6.71 % on March 2026 . This represents a CAGR of 8.04% over 6 years .
About Gujarat Kidney & Super Speciality Ltd
Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre.
Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad.
The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care.
About Kovai Medical Center & Hospital Ltd
Kovai Medical Center and Hospital Limited was incorporated as a Public Company in year 1985 and commenced its hospital operation in year 1990 with the flagship of Multi-Speciality Hospital at Coimbatore with a capacity of 200 Bed Hospital.
Thereafter, the Hospital set up the satellite centers at Coimbatore in the name of City Center, Sulur Hospital and Kovilpalayam Hospital and Erode in the name of Erode Speciality Hospital.
Today, KMCH has grown into a 2,250 bed multi-locational, multi-disciplinary Super specialty hospital, the best and most trusted in Southern India.
The Hospital is equipped with most modern equipments like CT Scanner, Angiograpy equipment with DSA, Operating Microscope, Mammography, C-arm, Color Doppler etc.
There are over 30 Medical Departments and 11 Operation Theatres at the Hospital.
FAQs for the comparison of Gujarat Kidney & Super Speciality Ltd and Kovai Medical Center & Hospital Ltd
Which company has a larger market capitalization, Gujarat Kidney & Super Speciality Ltd or Kovai Medical Center & Hospital Ltd?
Market cap of Gujarat Kidney & Super Speciality Ltd is 1,395 Cr while Market cap of Kovai Medical Center & Hospital Ltd is 6,277 Cr
What are the key factors driving the stock performance of Gujarat Kidney & Super Speciality Ltd and Kovai Medical Center & Hospital Ltd?
The stock performance of Gujarat Kidney & Super Speciality Ltd and Kovai Medical Center & Hospital Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Gujarat Kidney & Super Speciality Ltd and Kovai Medical Center & Hospital Ltd?
As of October 25, 2026, the Gujarat Kidney & Super Speciality Ltd stock price is INR ₹176.95. On the other hand, Kovai Medical Center & Hospital Ltd stock price is INR ₹5737.95.
How do dividend payouts of Gujarat Kidney & Super Speciality Ltd and Kovai Medical Center & Hospital Ltd compare?
To compare the dividend payouts of Gujarat Kidney & Super Speciality Ltd and Kovai Medical Center & Hospital Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.